Join to View Full Profile
4921 Parkview Pl5th Floor, Suite CSaint Louis, MO 63110
Phone+1 314-362-3500
Fax+1 314-362-4096
Are you Dr. Levisetti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matteo Levisetti, MD is an endocrinologist in Saint Louis, Missouri.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2004
- University of ChicagoResidency, Internal Medicine, 1998 - 2000
- Johns Hopkins UniversityResidency, Surgery, 1996 - 1996
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1996
Publications & Presentations
PubMed
- 6 citationsModel-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor...Jason H. Williams, Chandrasekhar Udata, Bishu J Ganguly, Samantha L. Bucktrout, Tenshang Joh
The AAPS Journal. 2020-01-03 - 27 citationsImmunomodulatory activity of humanized anti–IL-7R monoclonal antibody RN168 in subjects with type 1 diabetesKevan C. Herold, Samantha L. Bucktrout, Xiao Wang, Bruce W. Bode, Stephen E. Gitelman
JCI Insight. 2019-12-19 - 15 citationsThe effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtil...Barry Gumbiner, Tenshang Joh, Hong Liang, Hong Wan, Matteo Levisetti
Cardiovascular Therapeutics. 2018-02-01
Press Mentions
- Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 25th, 2023
- Cue Biopharma, Inc. (NASDAQ:CUE) Q4 2022 Earnings Call TranscriptMarch 24th, 2023
- Henry Skinner Buys Time in the Fight Against Antimicrobial Resistance; Vertex's Michael Parini Becomes President and COO at Freeline While CFO Brian Silver Plans His ExitFebruary 19th, 2021